Spectral Medical

Spectral Medical Inc. is a Canadian company based in Toronto, dedicated to developing and commercializing treatments for septic shock. The firm specializes in the Endotoxin Activity Assay (EAA), a rapid in vitro diagnostic test designed to detect components of gram-negative bacterial cell walls. Additionally, it offers the Toraymyxin therapeutic hemoperfusion device, which effectively removes endotoxins from the bloodstream. Beyond these primary products, Spectral Medical also produces and markets proprietary reagents, recombinant proteins, antibodies, and calibrators for research and development purposes. The company, originally known as Spectral Diagnostics Inc., rebranded in December 2014 and was founded in 1991.